New Covid variant spreads from Canada to US, Europe & Asia: What we know about PJ.2.1

AI Summary

The PJ.2.1 Covid-19 variant has been reported across Canada, the United States, Europe and Asia, with laboratory analyses suggesting increased cell-entry capability and stronger ACE2 receptor affinity. Its impact on transmissibility, severity and public health remains uncertain, and further research and surveillance are needed.

In 2026, the emergence of the PJ.2.1 Covid-19 variant has sparked concern as it rapidly spreads across various nations. Laboratory analyses reveal its enhanced ability to penetrate human cells compared to earlier strains. While it showcases limited evasion of antibodies, its increased affinity for the ACE2 receptor raises alarms over transmissibility. Ongoing surveillance and further studies are crucial to grasp its impact on disease severity and overall public health.